Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$5.69
-0.52%today
MKT CAP
$925M
-2.6% · 1Y
Earnings History
-28.8%
+6.0%
-7.9%
+11.2%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$5.69
Low
$8.00
Analyst Mean
$13.71
High
$27.00
7 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-5.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.5%
Institutional Ownership93.6%
Short % of Float12.94%
Days to Cover6.7d
1 Week-5.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CARSON WILLIAM H. | Director | Buy | 8,000 | $6.20 | $0.05M | 2026-04-10 |
| CARSON WILLIAM H. | Director | Buy | 8,000 | $5.67 | $0.05M | 2026-03-10 |
| LEW JENNIFER | Chief Financial Officer | Sale | 5,565 | $5.42 | $0.03M | 2026-03-02 |
| DANANBERG JAMIE | Officer | Sale | 5,820 | $5.43 | $0.03M | 2026-03-02 |
| OVERDORF MICHAEL | Officer | Sale | 4,339 | $5.42 | $0.02M | 2026-03-02 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| FMR, LLC | institution | 6.29% | $0.06B | -7.75% | 2025-12-31 |
| Redmile Group, LLC | institution | 6.18% | $0.06B | +59.52% | 2025-12-31 |
| BVF Inc. | institution | 5.62% | $0.05B | +30.40% | 2025-12-31 |
| Blackrock Inc. | institution | 5.51% | $0.05B | +13.44% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.77% | $0.04B | +32.87% | 2025-12-31 |
| Adage Capital Partners GP L.L.C. | institution | 3.38% | $0.03B | +266.67% | 2025-12-31 |
| Bain Capital Life Sciences Investors, LLC | institution | 3.23% | $0.03B | +0.00% | 2025-12-31 |
| Bellevue Group AG | institution | 3.17% | $0.03B | +0.00% | 2025-12-31 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 2.91% | $0.03B | +2.16% | 2026-02-28 |
| State Street Corporation | institution | 2.86% | $0.03B | +126.90% | 2025-12-31 |
| Ameriprise Financial, Inc. | institution | 2.68% | $0.02B | +98.36% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.65% | $0.02B | +38.77% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 2.46% | $0.02B | +69.68% | 2026-03-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.95% | $0.02B | +31.06% | 2026-03-31 |
| Columbia Acorn Trust-Columbia Acorn Fund | fund | 1.10% | $0.01B | +100.00% | 2025-12-31 |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | fund | 0.92% | $0.01B | +251.56% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.90% | $0.01B | +17.21% | 2025-12-31 |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | fund | 0.86% | $0.01B | +2.98% | 2026-01-31 |
| Fidelity Select Portfolios-Select Pharmaceuticals Portfolio | fund | 0.78% | $0.01B | +0.00% | 2026-02-28 |
| Fidelity Select Portfolios-Select Health Care Portfolio | fund | 0.74% | $0.01B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ANNX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.